Augmented replicative capacity of the boosting antigen improves the protective efficacy of heterologous prime-boost vaccine regimens.
about
Overcoming tumor resistance by heterologous adeno-poxvirus combination therapy.Development of novel replication-defective lymphocytic choriomeningitis virus vectors expressing SIV antigens.Novel Concepts for HIV Vaccine Vector Design.Features of Effective T Cell-Inducing Vaccines against Chronic Viral Infections.
P2860
Augmented replicative capacity of the boosting antigen improves the protective efficacy of heterologous prime-boost vaccine regimens.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Augmented replicative capacity ...... prime-boost vaccine regimens.
@ast
Augmented replicative capacity ...... prime-boost vaccine regimens.
@en
type
label
Augmented replicative capacity ...... prime-boost vaccine regimens.
@ast
Augmented replicative capacity ...... prime-boost vaccine regimens.
@en
prefLabel
Augmented replicative capacity ...... prime-boost vaccine regimens.
@ast
Augmented replicative capacity ...... prime-boost vaccine regimens.
@en
P2093
P2860
P356
P1433
P1476
Augmented replicative capacity ...... prime-boost vaccine regimens.
@en
P2093
Erica N Borducchi
Jeffrey E Teigler
Lily Parenteau
Nicholas M Provine
Pablo Penaloza-MacMaster
Rebecca C Obeng
Stephen Blackmore
P2860
P304
P356
10.1128/JVI.00406-14
P577
2014-03-19T00:00:00Z